Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA User Fee Legislation: Is Sen. Burr’s ‘Clean’ Bill A Lifeline – Or A Wrench In The Works?
15 Jul 2022
•
By
Derrick Gingery
SEN. BURR SUGGESTS THAT HIS STRIPPED-DOWN, ‘CLEAN’ USER FEE BILL MAY BE THE BEST WAY TO AVOID LAYOFF NOTIFICATIONS AT FDA. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from User Fees
More from Pathways & Standards